High cut‐off dialysis in chronic haemodialysis patients. (December 2015)

• Record Type: Journal Article
• Authors: Girndt, Matthias; Fiedler, Roman; Martus, Peter; Pawlak, Michael; Storr, Markus; Bohler, Torsten; Glomb, Marcus A.; Liehr, Kristin; Henning, Christian; Templin, Markus; Trojanowicz, Bogusz; Ulrich, Christof; Werner, Kristin; Zickler, Daniel; Schindler, Ralf
• Is Part Of: European journal of clinical investigation. Volume 45:Number 12(2015:Dec.)
• Page Start: 1333
• Page End: 1340
• Publication Date: 2015-12
• Subjects: High cut‐off membrane -- haemodialysis -- inflammation -- monocytes -- multiplex immunoassay; Pathology -- Periodicals; Medical research -- Periodicals; 616.075
• DOI: 10.1111/eci.12559
• Languages: English
• ISSNs: 0014-2972

Abstract

Abstract: Background: Haemodialysis patients suffer from chronic systemic inflammation and high incidence of cardiovascular disease. One cause for this may be the failure of diseased kidneys to eliminate immune mediators. Current haemodialysis treatment achieves insufficient elimination of proteins in the molecular weight range 15–45 kD. Thus, high cut‐off dialysis might improve the inflammatory state. Design: In this randomized crossover trial, 43 haemodialysis patients were treated for 3 weeks with high cut‐off or high‐flux dialysis. Inflammatory plasma mediators, monocyte subpopulation distribution and leucocyte gene expression were quantified. Results: High cut‐off dialysis supplemented by a low‐flux filter did not influence the primary end‐point, expression density of CD162 on monocytes. Nevertheless, treatment reduced multiple immune mediators in plasma. Such reduction proved – at least for some markers – to be a sustained effect over the interdialytic interval. Thus, for example, soluble TNF‐receptor 1 concentration predialysis was reduced from median 13·3 (IQR 8·9–17·2) to 9·7 (IQR 7·5–13·2) ng/mL with high cut‐off while remaining constant with high‐flux treatment. The expression profile of multiple proinflammatory genes in leucocytes was significantly dampened. Treatment was well tolerated although albumin losses in high cut‐off dialysis would be prohibitive against long‐term use. Conclusions: The study shows for the first time that a dampening effect of high cut‐off dialysis on systemic inflammation is achievable. Earlier studies had failed due to short study duration or insufficient dialysis efficacy. Removal of soluble mediators from the circulation influences cellular activation levels in leucocytes. Continued development of less albumin leaky membranes with similar cytokine elimination is justified.